Overview

A Study In Patients Who Will Undergo Surgical Removal Of Non-Small Cell Lung Cancer To Evaluate Molecular Changes That Occur In Tumor Tissue After Short Term Exposure To PF-00299804

Status:
Terminated
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
This study will enroll patients who are planned to undergo surgical removal of their tumor. The goal of the study is to evaluate the changes that occur in the tumor after brief (about 8 days) exposure to the study drug.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer